SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarter ended June 30, 2004
OR
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission file number 1-14287
USEC Inc.
Delaware | 52-2107911 | |
(State of incorporation) | (I.R.S. Employer Identification No.) |
2 Democracy Center
6903 Rockledge Drive,
Bethesda, MD 20817
(301) 564-3200
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X No
Indicate by check mark whether the registrant is an accelerated filer (as
defined by Rule 12b-2 of the Securities Exchange Act of 1934.)
Yes X No
As of June 30, 2004, there were 84,286,000 shares of Common Stock issued and outstanding.
TABLE OF CONTENTS
Page | ||||
PART I |
||||
Financial Information |
||||
Consolidated Condensed Financial Statements: |
||||
Consolidated Condensed Balance Sheets at June 30, 2004 (Unaudited)
and December 31, 2003 |
3 | |||
Consolidated Condensed Statements of Income for the Three and Six Months
Ended June 30, 2004 and 2003 (Unaudited) |
4 | |||
Consolidated Condensed Statements of Cash Flows for the Six Months
Ended June 30, 2004 and 2003 (Unaudited) |
5 | |||
Notes to Consolidated Condensed Financial Statements (Unaudited) |
6 | |||
Managements Discussion and Analysis of Financial Condition
and Results of Operations |
13 | |||
Quantitative and Qualitative Disclosures about Market Risk |
23 | |||
Controls and Procedures |
24 | |||
PART II |
||||
Other Information |
||||
Item 1. Legal Proceedings |
25 | |||
Item 4. Submission of Matters to a Vote of Security Holders |
26 | |||
Item 6. Exhibits and Reports on Form 8-K |
27 | |||
Signature |
28 | |||
Exhibit Index |
29 |
This Quarterly Report on Form 10-Q contains forward-looking information (within the meaning of the Private Securities Litigation Reform Act of 1995) that involves risks and uncertainty, including certain assumptions regarding the future performance of USEC. Actual results and trends may differ materially depending upon a variety of factors, including, without limitation, market demand for USECs products, pricing trends in the uranium and enrichment markets, deliveries under the Russian Contract, the availability and cost of electric power, implementing agreements with the Department of Energy (DOE) regarding uranium inventory remediation and the use of centrifuge technology and facilities, satisfactory performance of the American Centrifuge technology at various stages of demonstration, USECs ability to successfully execute its internal performance plans, the refueling cycles of USECs customers, final determinations of environmental and other costs, the outcome of litigation and trade actions, performance under government contracts and audits of allowable costs on government contract work, and the impact of any government regulation. Revenue and operating results can fluctuate significantly from quarter to quarter, and in some cases, year to year.
2
USEC Inc.
CONSOLIDATED CONDENSED BALANCE SHEETS
(millions)
(Unaudited) | ||||||||
June 30, | December 31, | |||||||
2004 | 2003 | |||||||
ASSETS |
||||||||
Current Assets |
||||||||
Cash and cash equivalents |
$ | 32.4 | $ | 249.1 | ||||
Accounts receivable trade |
203.0 | 254.5 | ||||||
Inventories |
1,112.5 | 883.2 | ||||||
Other |
24.7 | 39.9 | ||||||
Total Current Assets |
1,372.6 | 1,426.7 | ||||||
Property, Plant and Equipment, net |
180.7 | 185.1 | ||||||
Other Assets |
||||||||
Deferred income taxes |
54.0 | 52.5 | ||||||
Prepayment and deposit for depleted uranium |
23.5 | 47.1 | ||||||
Prepaid pension benefit costs |
79.5 | 76.3 | ||||||
Inventories |
227.7 | 266.1 | ||||||
Total Other Assets |
384.7 | 442.0 | ||||||
Total Assets |
$ | 1,938.0 | $ | 2,053.8 | ||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
Current Liabilities |
||||||||
Accounts payable and accrued liabilities |
$ | 171.7 | $ | 188.3 | ||||
Payables under Russian Contract |
90.8 | 119.3 | ||||||
Uranium owed to customers and suppliers |
41.4 | 45.0 | ||||||
Termination settlement obligation under power purchase agreement |
| 33.2 | ||||||
Deferred revenue and advances from customers |
30.1 | 25.8 | ||||||
Total Current Liabilities |
334.0 | 411.6 | ||||||
Long-Term Debt |
500.0 | 500.0 | ||||||
Other Liabilities |
||||||||
Deferred revenue and advances from customers |
6.7 | 13.5 | ||||||
Depleted uranium disposition |
28.9 | 53.5 | ||||||
Postretirement health and life benefit obligations |
142.5 | 138.1 | ||||||
Lease turnover and other liabilities |
52.3 | 50.9 | ||||||
Total Other Liabilities |
230.4 | 256.0 | ||||||
Stockholders Equity |
873.6 | 886.2 | ||||||
Total Liabilities and Stockholders Equity |
$ | 1,938.0 | $ | 2,053.8 | ||||
See notes to consolidated condensed financial statements.
3
USEC Inc.
CONSOLIDATED CONDENSED STATEMENTS OF INCOME (Unaudited)
(millions, except per share data)
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2004 | 2003 | 2004 | 2003 | |||||||||||||
As restated | As restated | |||||||||||||||
Revenue: |
||||||||||||||||
Separative work units |
$ | 196.2 | $ | 270.7 | $ | 323.6 | $ | 532.4 | ||||||||
Uranium |
81.0 | 51.7 | 95.0 | 76.2 | ||||||||||||
U.S. Government contracts |
41.4 | 40.2 | 80.0 | 81.1 | ||||||||||||
Total revenue |
318.6 | 362.6 | 498.6 | 689.7 | ||||||||||||
Cost of sales: |
||||||||||||||||
Separative work units and uranium |
225.9 | 281.7 | 353.2 | 533.3 | ||||||||||||
U.S. Government contracts |
37.3 | 39.3 | 74.4 | 79.7 | ||||||||||||
Total cost of sales |
263.2 | 321.0 | 427.6 | 613.0 | ||||||||||||
Gross profit |
55.4 | 41.6 | 71.0 | 76.7 | ||||||||||||
Centrifuge demonstration costs |
10.6 | 11.0 | 20.0 | 20.6 | ||||||||||||
Selling, general and administrative |
15.9 | 14.8 | 31.9 | 29.2 | ||||||||||||
Operating income |
28.9 | 15.8 | 19.1 | 26.9 | ||||||||||||
Interest expense |
10.4 | 9.7 | 19.8 | 18.9 | ||||||||||||
Interest (income) |
(.8 | ) | (1.4 | ) | (1.5 | ) | (3.1 | ) | ||||||||
Income before income taxes |
19.3 | 7.5 | .8 | 11.1 | ||||||||||||
Provision for income taxes |
7.6 | 3.2 | .3 | 4.7 | ||||||||||||
Net income |
$ | 11.7 | $ | 4.3 | $ | .5 | $ | 6.4 | ||||||||
Net income per share basic and diluted |
$ | .14 | $ | .05 | $ | .01 | $ | .08 | ||||||||
Dividends per share |
$ | .1375 | $ | .1375 | $ | .2750 | $ | .2750 | ||||||||
Average number of shares outstanding |
84.0 | 82.2 | 83.5 | 82.1 |
See notes to consolidated condensed financial statements.
4
USEC Inc.
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited)
(millions)
Six Months Ended | ||||||||
June 30, | ||||||||
2004 | 2003 | |||||||
Cash Flows from Operating Activities |
||||||||
Net income |
$ | .5 | $ | 6.4 | ||||
Adjustments to reconcile net income to net cash provided by
(used in) operating activities: |
||||||||
Depreciation and amortization |
15.5 | 14.3 | ||||||
Deferred revenue and advances from customers |
(2.5 | ) | (19.6 | ) | ||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable (increase) decrease |
51.5 | (22.7 | ) | |||||
Inventories net (increase) decrease |
(194.9 | ) | 14.5 | |||||
Payables under Russian Contract increase (decrease) |
(28.5 | ) | 35.6 | |||||
Payment of termination settlement obligation under
power purchase agreement |
(33.2 | ) | | |||||
Accounts payable and other net increase (decrease) |
1.0 | (5.4 | ) | |||||
Net Cash Provided by (Used in) Operating Activities |
(190.6 | ) | 23.1 | |||||
Cash Flows Used in Investing Activities |
||||||||
Capital expenditures |
(11.2 | ) | (14.9 | ) | ||||
Net Cash (Used in) Investing Activities |
(11.2 | ) | (14.9 | ) | ||||
Cash Flows Used in Financing Activities |
||||||||
Dividends paid to stockholders |
(23.0 | ) | (22.6 | ) | ||||
Common stock issued |
8.1 | 1.6 | ||||||
Net Cash (Used in) Financing Activities |
(14.9 | ) | (21.0 | ) | ||||
Net (Decrease) |
(216.7 | ) | (12.8 | ) | ||||
Cash and Cash Equivalents at Beginning of Period |
249.1 | 171.1 | ||||||
Cash and Cash Equivalents at End of Period |
$ | 32.4 | $ | 158.3 | ||||
Supplemental Cash Flow Information: |
||||||||
Interest paid |
$ | 17.2 | $ | 17.5 | ||||
Income taxes paid (refund) |
8.1 | (2.8 | ) |
See notes to consolidated condensed financial statements.
5
USEC Inc.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (Unaudited)
1. Basis of Presentation
The unaudited consolidated condensed financial statements as of and for the three and six months ended June 30, 2004 and 2003, have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. The unaudited consolidated condensed financial statements reflect all adjustments which are, in the opinion of management, necessary for a fair statement of the financial results for the interim period. Certain information and notes normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States have been omitted pursuant to such rules and regulations.
Operating results for the three and six months ended June 30, 2004, are not necessarily indicative of the results that may be expected for the year ending December 31, 2004. The unaudited consolidated condensed financial statements should be read in conjunction with the consolidated financial statements and related notes and managements discussion and analysis of financial condition and results of operations, included in the annual report on Form 10-K for the year ended December 31, 2003.
Certain amounts in the consolidated condensed financial statements have been reclassified to conform with the current presentation.
2. Centrifuge Costs
USEC is in the process of demonstrating the American Centrifuge uranium enrichment technology and expects to construct and operate the American Centrifuge Plant by 2010. Costs relating to the demonstration and deployment of the American Centrifuge technology are charged to expense or capitalized based on the nature of the activities.
Centrifuge costs relating to the process of demonstrating the American Centrifuge technology are charged to expense as incurred. Demonstration costs include licensing, engineering, assembling and testing centrifuge machines and equipment at centrifuge test facilities located in Oak Ridge, Tennessee and at the American Centrifuge Demonstration Facility in Piketon, Ohio.
Capitalized costs relating to the American Centrifuge Plant include, or will include, Nuclear Regulatory Commission (NRC) licensing, engineering, centrifuge machines and equipment, leasehold improvements and other costs directly associated with deploying the American Centrifuge Plant. Capitalized centrifuge costs are recorded in property, plant and equipment as part of construction work in progress. The continued capitalization of such costs is subject to ongoing review and successful project completion, including NRC licensing, financing of capital costs, and installation and operation of centrifuge machines and equipment. If conditions change and deployment was no longer probable, costs that were previously capitalized would be charged to expense.
6
3. Restatement of Statements of Income
USEC performs contract work for DOE and DOE contractors at the Portsmouth and Paducah plants. Beginning in the fourth quarter of 2003, billings under government contracts are reported as part of revenue, and costs are reported as part of costs and expenses. In prior periods, the net amount of income or expense for government contracts had been reported as part of other income (expense), net. The statements of income for the three and six months ended June 30, 2003, have been restated to conform to the current presentation. Revenue and cost of sales increased, and other income (expense), net was adjusted by the net amount. There was no effect on net income or net income per share as a result of the change. The effects of the restatement are as follows (in millions, except per share data):
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, 2003 | June 30, 2003 | |||||||||||||||
As previously | As previously | |||||||||||||||
reported | As restated | reported | As restated | |||||||||||||
Revenue |
$ | 322.4 | $ | 362.6 | $ | 608.6 | $ | 689.7 | ||||||||
Cost of sales |
281.7 | 321.0 | 533.3 | 613.0 | ||||||||||||
Interest (income) |
(1.4 | ) | (1.4 | ) | (3.1 | ) | (3.1 | ) | ||||||||
Other (income) expense, net |
(.9 | ) | | (1.4 | ) | | ||||||||||
Net income |
4.3 | 4.3 | 6.4 | 6.4 | ||||||||||||
Net income per share |
$ | .05 | $ | .05 | $ | .08 | $ | .08 |
4. Inventories
Inventories were as follows (in millions):
June 30, | December 31, | |||||||
2004 | 2003 | |||||||
Current assets: |
||||||||
Separative work units |
$ | 880.2 | $ | 673.0 | ||||
Uranium |
212.0 | 187.9 | ||||||
Materials and supplies |
20.3 | 22.3 | ||||||
1,112.5 | 883.2 | |||||||
Long-term assets: |
||||||||
Out-of-specification uranium |
132.1 | 156.2 | ||||||
Highly enriched uranium from
Department of Energy |
95.6 | 109.9 | ||||||
227.7 | 266.1 | |||||||
Current liabilities: |
||||||||
Uranium owed to customers and suppliers |
(41.4 | ) | (45.0 | ) | ||||
Inventories, net |
$ | 1,298.8 | $ | 1,104.3 | ||||
Replacing Out-of-Specification Natural Uranium Inventory
In December 2000, USEC reported to DOE that 9,550 metric tons of natural uranium with a cost of $237.5 million transferred to USEC from DOE prior to privatization in 1998 may contain elevated levels of technetium that would put the uranium out of specification for commercial use. Out of
7
specification means that the uranium would not meet the industry standard as defined in the American Society for Testing and Materials (ASTM) specification Standard Specification for Uranium Hexafluoride for Enrichment. The levels of technetium exceeded allowable levels in the ASTM specification.
Under the DOE-USEC Agreement signed in June 2002 (DOE-USEC Agreement), DOE is obligated to replace or remediate the affected uranium inventory, and USEC has been working with DOE to implement this process. Under the DOE-USEC Agreement, the remediated inventory would meet the ASTM specification or be acceptable to USEC for use as feed material in its enrichment plant. USEC has been operating facilities at the Portsmouth plant for DOE since June 2002, and, at June 30, 2004, had completed the processing and removal of contaminants from 4,552 metric tons (or 48%) of the out-of-specification uranium. In June 2004, DOE approved a cost ratification request and, in July 2004, DOE paid $10.8 million to USEC relating to the processing of out-of-specification uranium during the period December 2003 to April 2004. In April 2004, USEC and DOE concluded a work authorization for USEC to process out-of-specification uranium for DOE through September 30, 2004, and USEC and DOE are negotiating contract terms for further extensions. At June 30, 2004, the remaining amount of uranium inventory that may contain elevated levels of technetium and be out of specification is 4,998 metric tons with a cost of $132.1 million reported as part of long-term assets.
Pursuant to the terms of the DOE-USEC Agreement, DOE was obligated, as of March 31, 2003, to exchange, replace or reimburse USEC for 2,116 metric tons of the remaining out-of-specification natural uranium. In June 2004, DOE notified USEC that, subject to certain conditions and restrictions, it was authorizing the transfer of 2,116 metric tons of uranium to USEC in exchange for 2,116 metric tons of out-of-specification uranium. Although the exchange had not been completed as of June 30, 2004, USEC expects that DOE will fulfill its obligation.
DOEs obligations to replace or remediate all remaining out-of-specification natural uranium continue until all such uranium is replaced or remediated, and DOEs obligations survive any termination of the DOE-USEC Agreement as long as USEC is producing low enriched uranium containing at least 1 million separative work units per year at the Paducah plant or at a new enrichment facility. DOEs obligations to replace or remediate out-of-specification natural uranium are subject to availability of appropriated funds and legislative authority, and compliance with applicable law. Although the parties are pursuing any necessary legislative or administrative authority, there can be no assurance that Congress will pass requisite legislation or that DOE will act on existing regulatory authority. An impairment in the valuation of uranium inventory would result if DOE fails to exchange, replace, clean up or reimburse USEC for some or all of the out-of-specification natural uranium for which DOE has assumed responsibility. Depending on the amount, an impairment could have an adverse effect on USECs financial condition and results of operations.
5. Special Charges for Consolidating Plant Operations
The accrued liability resulting from special charges for consolidating plant operations amounted to $12.9 million at December 31, 2003, and related to lease turnover and other exit costs. In the six months ended June 30, 2004, the amount of $5.2 million was paid, and the remaining amount of $7.7 million was reclassified to a lease turnover obligation included in current liabilities.
8
6. Stock-Based Compensation
Compensation expense for employee stock compensation plans is measured using the intrinsic value-based method of accounting prescribed by Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees. As long as stock options are granted at an exercise price that is equal to the market value of common stock at the date of grant, there is no compensation expense for the grant, vesting or exercise of stock options.
Grants of restricted stock result in deferred compensation based on the market value of common stock at the date of grant. Deferred compensation is amortized to expense on a straight-line basis over the vesting period. Compensation expense for awards of restricted stock units is accrued over a three-year performance period.
Under the disclosure provisions of Statement of Financial Accounting Standards No. 148, Accounting for Stock-Based Compensation Transition and Disclosure, pro forma net income assumes that compensation expense relating to stock options and to shares of common stock purchased by employees at 85% of the market price under the Employee Stock Purchase Plan is recognized based on the fair value recognition provisions of Statement of Financial Accounting Standards No. 123, Accounting for Stock-Based Compensation. The fair value of stock options is measured at the date of grant based on the Black-Scholes option pricing model and is amortized to expense over the vesting period. The following table illustrates the effect on net income (loss) if the fair value method of accounting had been applied (in millions, except per share data):
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2004 | 2003 | 2004 | 2003 | |||||||||||||
Net income, as reported |
$ | 11.7 | $ | 4.3 | $ | .5 | $ | 6.4 | ||||||||
Add: Stock-based compensation expense included
in reported results, net of tax |
1.0 | .9 | 2.0 | 1.4 | ||||||||||||
Deduct: Stock-based compensation expense
determined under
the fair value method, net of tax |
(1.7 | ) | (1.2 | ) | (3.4 | ) | (2.2 | ) | ||||||||
Pro forma net income (loss) |
$ | 11.0 | $ | 4.0 | $ | (.9 | ) | $ | 5.6 | |||||||
Net income (loss) per share: |
||||||||||||||||
As reported |
$ | .14 | $ | .05 | $ | .01 | $ | .08 | ||||||||
Pro forma |
$ | .13 | $ | .05 | $ | (.01 | ) | $ | .07 |
9
7. Pension and Postretirement Health and Life Benefits
The components of net benefit costs for pension and postretirement health and life benefit plans were as follows (in millions):
Defined Benefit Pension Plans | Postretirement Health and Life Benefits Plans | |||||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||
June 30, | June 30, | June 30, | June 30, | |||||||||||||||||||||||||||||
2004 | 2003 | 2004 | 2003 | 2004 | 2003 | 2004 | 2003 | |||||||||||||||||||||||||
Service cost |
$ | 3.5 | $ | 2.2 | $ | 6.9 | $ | 5.3 | $ | 1.8 | $ | 1.5 | $ | 3.9 | $ | 3.5 | ||||||||||||||||
Interest cost |
9.7 | 7.7 | 18.7 | 16.5 | 3.8 | 3.8 | 7.4 | 7.2 | ||||||||||||||||||||||||
Expected return on plan assets
(gains) |
(12.9 | ) | (9.6 | ) | (25.6 | ) | (20.8 | ) | (1.2 | ) | (1.0 | ) | (2.4 | ) | (2.0 | ) | ||||||||||||||||
Amortization of prior service costs
(credit) |
.5 | | .6 | | (.6 | ) | (.7 | ) | (1.2 | ) | (1.3 | ) | ||||||||||||||||||||
Amortization of actuarial (gains)
losses |
.7 | 1.2 | .8 | 2.3 | .9 | | 1.4 | | ||||||||||||||||||||||||
Net benefit costs (income) |
$ | 1.5 | $ | 1.5 | $ | 1.4 | $ | 3.3 | $ | 4.7 | $ | 3.6 | $ | 9.1 | $ | 7.4 | ||||||||||||||||
Projected pension benefit obligations were 101% funded and postretirement health and life benefit obligations were 24% funded at December 31, 2003. In the six months ended June 30, 2004, USEC contributed $4.2 million to the defined benefit pension plans and $4.3 million to the postretirement health and life benefit plans. Cash contributions during the remainder of 2004 are expected as follows: $3.7 million for the defined benefit plans and $4.0 million for the postretirement health and life benefit plans.
New Accounting Standards
In December 2003, the Medicare Prescription Drug Improvement and Modernization Act of 2003 (Act) was enacted. The Act introduces a prescription drug benefit beginning in 2006 under Medicare (Medicare Part D) as well as a federal subsidy to sponsors of retiree healthcare benefit plans that provide a benefit that is at least actuarially equivalent to Medicare Part D. FASB Staff Position (FSP) No. 106-2, Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003, was issued by the Financial Accounting Standards Board in May 2004 effective for interim or annual periods beginning after June 15, 2004. The FSP provides guidance on accounting for the effects of the legislation. USEC is in the process of determining whether its postretirement health benefit plan is at least actuarially equivalent to Medicare Part D. The postretirement health benefit obligation and related benefit cost for 2004 and 2003 do not reflect effects of the legislation.
8. Stockholders Equity
Changes in stockholders equity were as follows (in millions, except per share data):
10
Common | ||||||||||||||||||||||||
Stock, | ||||||||||||||||||||||||
Par Value | Excess of | Retained | Total | |||||||||||||||||||||
$.10 per | Capital over | Earnings | Treasury | Deferred | Stockholders' | |||||||||||||||||||
share | Par Value | (Deficit) | Stock | Compensation | Equity | |||||||||||||||||||
Balance at December 31, 2003 |
$ | 10.0 | $ | 1,009.0 | $ | (4.6 | ) | $ | (127.7 | ) | $ | (.5 | ) | $ | 886.2 | |||||||||
Common stock issued: |
||||||||||||||||||||||||
Proceeds from the exercise of
stock options |
| .3 | | 7.2 | | 7.5 | ||||||||||||||||||
Restricted and other stock issued |
| | | 5.1 | (2.7 | ) | 2.4 | |||||||||||||||||
Dividends paid to stockholders |
| (23.0 | ) | | | | (23.0 | ) | ||||||||||||||||
Net income |
| | .5 | | | .5 | ||||||||||||||||||
Balance at June 30, 2004 |
$ | 10.0 | $ | 986.3 | $ | (4.1 | ) | $ | (115.4 | ) | $ | (3.2 | ) | $ | 873.6 | |||||||||
9. Settlement of Power Contract
In 2001 and prior years, USEC purchased electric power for the Portsmouth uranium enrichment plant under a contract with DOE. DOE acquired the power under a power purchase agreement with the Ohio Valley Electric Corporation (OVEC). USEC ceased uranium enrichment operations at the Portsmouth plant in 2001, and the power purchase agreement was terminated effective April 30, 2003. As a result of termination of the power purchase agreement, DOE was responsible for a portion of the costs incurred by OVEC for postretirement health and life insurance benefits and for the eventual decommissioning, demolition and shutdown of the coal-burning power generating facilities owned and operated by OVEC. In February 2004, OVEC and DOE, and DOE and USEC, entered into agreements and settled all the issues relating to the termination, and USEC paid the previously accrued amount of $33.2 million representing its share of the obligation.
10. Legal Matters
Environmental Matters
In 1998, USEC contracted with Starmet CMI (Starmet) to convert a small portion of USECs depleted uranium into a form that could be used in certain beneficial applications or disposed of at existing commercial disposal facilities. In 2002, Starmet ceased operations at its Barnwell, South Carolina facility.
In November 2002, USEC received notice from the U.S. Environmental Protection Agency (EPA) that EPA was undertaking removal action under the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA), as amended (commonly known as Superfund), to clean up two evaporation ponds and remove and dispose of certain drums and other material located at Starmets Barnwell site containing uranium and other byproducts of Starmets activities at the site. The notice also stated that EPA believed USEC as well as other parties, including agencies of the U.S. Government, are potentially responsible parties (PRPs) under CERCLA. In February 2004, USEC and certain federal agencies who have been identified as PRPs under CERCLA entered into an agreement with EPA, under which USEC is responsible for removing certain material from the site that is attributable to quantities of depleted uranium USEC had sent to the site. USEC has engaged contractors to remove and dispose of such material.
At June 30, 2004, USEC has an accrued liability of $8.1 million representing its current estimate of its share of costs to comply with the EPA settlement agreement and other costs associated with the
11
Starmet facility. Additional costs could be incurred due to a number of factors including, but not limited to, increases in costs associated with the removal and disposal of material from the Starmet site, increases in costs associated with remediation of the evaporation ponds, or a decision by EPA or the South Carolina Department of Health and Environmental Control to perform additional remediation at the site after completion of the removal and disposal activities. An allocation of costs to USEC in excess of the amounts that USEC has accrued at June 30, 2004, could have an adverse effect on USECs results of operations.
Other
USEC is subject to various other legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business. While the outcome of these claims cannot be predicted with certainty, USEC does not believe that the outcome of any of these legal matters will have a material adverse effect on its results of operations or financial condition.
11. Segment Information
USEC has two reportable segments: low enriched uranium (LEU) with two components, Separative Work Units (SWU) and uranium, and U.S. Government contracts. LEU is the primary business focus and includes sales of the SWU component of LEU, sales of both the SWU and uranium components of LEU, and sales of uranium. The U.S. Government contracts segment represents work performed for DOE and DOE contractors at the Portsmouth and Paducah plants.
Operating income for segment reporting is measured before selling, general and administrative expenses. Centrifuge demonstration costs are reported as charges against operating income of the LEU segment. There are no transactions between reportable segments that impact revenue or operating income before selling, general and administrative expenses.
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2004 | 2003 | 2004 | 2003 | |||||||||||||
(millions) | ||||||||||||||||
Revenue: |
||||||||||||||||
Low enriched uranium |
$ | 277.2 | $ | 322.4 | $ | 418.6 | $ | 608.6 | ||||||||
U.S. Government contracts |
41.4 | 40.2 | 80.0 | 81.1 | ||||||||||||
$ | 318.6 | $ | 362.6 | $ | 498.6 | $ | 689.7 | |||||||||
Operating income before selling, general, and
administrative expenses: |
||||||||||||||||
Low enriched uranium |
$ | 51.3 | $ | 40.7 | $ | 65.4 | $ | 75.3 | ||||||||
Less: Centrifuge demonstration costs |
10.6 | 11.0 | 20.0 | 20.6 | ||||||||||||
40.7 | 29.7 | 45.4 | 54.7 | |||||||||||||
U.S. Government contracts |
4.1 | .9 | 5.6 | 1.4 | ||||||||||||
Operating income before selling, general, and
administrative expenses |
44.8 | 30.6 | 51.0 | 56.1 | ||||||||||||
Selling, general, and administrative |
15.9 | 14.8 | 31.9 | 29.2 | ||||||||||||
Operating income |
28.9 | 15.8 | 19.1 | 26.9 | ||||||||||||
Interest expense, net of interest income |
9.6 | 8.3 | 18.3 | 15.8 | ||||||||||||
Income before income taxes |
$ | 19.3 | $ | 7.5 | $ | .8 | $ | 11.1 | ||||||||
12
USEC Inc.
MANAGEMENTS DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion should be read in conjunction with, and is qualified in its entirety by reference to, the consolidated financial statements and related notes and managements discussion and analysis of financial condition and results of operations included in the annual report on Form 10-K for the year ended December 31, 2003.
Overview
USEC Inc. (USEC), a global energy company, is the worlds leading supplier of low enriched uranium (LEU) for commercial nuclear power plants. LEU is a fundamental component in the production of nuclear fuel for reactors to produce electricity. USEC:
| supplies LEU to both domestic and international utilities for use in about 155 nuclear reactors worldwide, | |||
| is the exclusive executive agent for a nuclear nonproliferation program with Russia, known as Megatons to Megawatts, | |||
| is in the process of deploying what is anticipated to be the worlds most efficient uranium enrichment technology known as the American Centrifuge, and | |||
| performs contract work for DOE and DOE contractors at the Paducah and Portsmouth plants. |
Low Enriched Uranium
LEU is sold and measured by the components separative work units (SWU) and uranium. SWU is a standard unit of measurement which represents the effort required to separate specific quantities of uranium containing .711% of U235 into two components: enriched uranium having a higher percentage of U235 and depleted uranium having a lower percentage of U235. The SWU contained in LEU is calculated using an industry standard formula based on the physics of enrichment. The amount of enrichment contained in LEU under this formula is commonly referred to as the SWU component.
Supplier of LEU
USEC produces or acquires LEU from two principal sources. LEU is produced at the gaseous diffusion plant in Paducah, Kentucky, and LEU is acquired by purchasing the SWU component of LEU from Russia. Revenue is derived primarily from sales of the SWU component of LEU, from sales of both the SWU and uranium components of LEU, and from sales of uranium. The gaseous diffusion process uses significant amounts of electric power to enrich uranium, and costs for electric power typically represent 60% of production costs at the Paducah plant. USEC purchases about 78% of the electric power for the Paducah plant from Tennessee Valley Authority. USEC maintains the Portsmouth gaseous diffusion plant in Piketon, Ohio in a cold standby condition under a contract with DOE. The gaseous diffusion plants are leased from DOE and are regulated by the U.S. Nuclear Regulatory Commission (NRC). In 2003, USEC applied for and NRC granted a renewal of the certifications for the five-year period ending December 2008.
13
Megatons to Megawatts
USEC is the exclusive executive agent for the U.S. Government under a government-to-government agreement (the Russian Contract) to purchase the SWU component of LEU derived from highly enriched uranium contained in decommissioned nuclear warheads in Russia. USEC expects purchases under the Russian Contract will be about half of its supply mix in 2004.
American Centrifuge
USEC is in the process of demonstrating the American Centrifuge uranium enrichment technology at centrifuge test facilities located in Oak Ridge, Tennessee and at the American Centrifuge Demonstration Facility in Piketon, Ohio. In January 2004, USEC selected Piketon, Ohio as the site for the American Centrifuge Plant. USEC expects to build and operate the American Centrifuge Plant by 2010. The plant is expected to cost up to $1.5 billion, employ up to 500 people, and reach an initial annual production level of 3.5 million SWU by 2010. USEC plans to submit the license application for the American Centrifuge Plant to the NRC in August 2004, ahead of the milestone schedule in the DOE-USEC Agreement.
U.S. Government Contracts
USEC performs, and earns revenue from, contract work for DOE and DOE contractors at the Paducah and Portsmouth plants. DOE has extended the cold standby contract at the Portsmouth plant through September 2005. USEC operates facilities at the Portsmouth plant to process and clean up out-of-specification uranium for DOE under a work authorization that extends through September 2004; USEC and DOE are negotiating contract terms for further extensions.
Recent Event
On July 29, 2004, USEC announced that it will purchase NAC International from Pinnacle West Capital Corporation. The acquisition will enable USEC to offer nuclear utility customers an expanded portfolio of products and services, including transportation and storage systems for spent nuclear fuel. The $16 million cash transaction is expected to close later in 2004, subject to customary closing conditions.
Critical Accounting Estimates
The summary of significant accounting policies and the other notes to the consolidated financial statements included in the annual report on Form 10-K provide a description of relevant information regarding USECs significant and critical accounting estimates with respect to the following:
| revenue recognition, deferred revenue and advances from customers, | |||
| inventories of uranium and SWU, inventory costing methods, classifications and valuations, | |||
| costs for the future disposition of depleted uranium and lease turnover, | |||
| pension and postretirement health and life benefit costs and obligations, | |||
| deferred income taxes and related valuation allowance, and | |||
| centrifuge costs. |
14
Revenue includes estimates and judgments relating to the recognition of deferred revenue and price adjustments under contracts with customers that involve pricing based on inflation rates and customers nuclear fuel requirements. SWU and uranium inventories include estimates and judgments for production quantities and costs and judgments regarding the replacement or remediation of out-of-specification uranium by DOE. Production costs include estimates of future costs for the storage, transportation and disposition of depleted uranium, the treatment and disposal of hazardous, low-level radioactive and mixed wastes, and plant lease turnover costs. Pension and postretirement health and life benefit costs and obligations are based on provisions of the plans and actuarial assumptions that involve estimates and judgments, including expected returns on plan assets, discount rates, and healthcare cost trend rates. Income taxes include estimates and judgments for the tax bases of assets and liabilities and the future recoverability of deferred tax assets. Costs relating to the demonstration and deployment of the American Centrifuge technology are charged to expense or capitalized based on the nature of the activities.
Results of Operations Three and Six Months Ended June 30, 2004 and 2003
Revenue
SWU revenue declined $74.5 million (or 28%) in the three months and $208.8 million (or 39%) in the six months ended June 30, 2004, compared with the corresponding periods in 2003. The reductions reflect lower volumes of SWU sold and a decline in the average price per SWU billed to customers. The volume of SWU sold declined 27% in three months and 37% in the six months, and the average price declined less than 1% in the three months and 4% in the six months ended June 30, 2004. The decline in volume reflects the timing of customer orders, lower contractual commitments from customers, and temporary shutdowns of certain nuclear reactors in Japan. The reduction in the average price billed in the six-month period reflects sales to customers based predominantly on contractual commitments from the late 1990s when SWU prices were severely depressed.
USEC expects that revenue from sales of SWU will be about $1.0 billion in 2004, a decline of 11% from 2003 resulting from the temporary shutdown of certain nuclear reactors in Japan, lower contractual commitments from customers, and the timing of customer orders. USEC expects the average price billed to customers in 2004 will be about the same as in 2003.
The timing of customer orders affected revenue in the 2004 periods. Revenue and operating results can fluctuate significantly from quarter to quarter, and in some cases, year to year. Customer requirements are determined by refueling schedules for nuclear reactors, which are affected by, among other things, the seasonal nature of electricity demand, reactor maintenance, and reactors beginning or terminating operations. Thus, some reactors are scheduled for annual or two-year refuelings in the spring or fall, or for 18-month cycles alternating between both seasons. Customer orders for the SWU component of LEU are large in amount, typically averaging $12.0 million per order. Customer requirements and orders are more predictable over the longer term, and USEC believes its performance is best measured on an annual, or even longer, business cycle.
Reductions in contractual commitments from customers contributed to the reductions in revenue in the 2004 periods. Contractual commitments have declined in recent years, primarily due to aggressive pricing by, and loss of sales commitments to, foreign competitors in prior years. In December 2000, the U.S. Department of Commerce (DOC) initiated investigations into unfair pricing, or dumping, and government subsidization of imports of LEU produced by European enrichers Eurodif and Urenco, and subsequently, market prices increased significantly. However,
15
since contractual commitments from customers are typically long-term, the effects of aggressive or unfair trade practices by foreign competitors prior to the increase in market prices have contributed to the reductions in revenue in the 2004 periods.
Revenue could be adversely affected by actions of the NRC or nuclear regulators in foreign countries issuing orders to delay, suspend or shut down nuclear reactor operations within their jurisdictions. Beginning in late 2002, 17 reactors were temporarily shut down in Japan by the Ministry of Economy, Trade and Industry. USEC provides LEU for seven of the reactors that have returned to service as well as three reactors that remain shutdown. Beginning in 2004, the shutdowns and the delay in restarting the remaining reactors has postponed the utilitys requirements for reloading fuel. USEC expects revenue for the remainder of 2004 and, to a lesser extent, for 2005 will be reduced as a result of the shutdowns. A continued shutdown of reactors in Japan would have an additional adverse effect on USECs revenue and results of operations.
Revenue from sales of uranium increased $29.3 million (or 57%) in the three months and $18.8 million (or 25%) in the six months ended June 30, 2004, compared with the corresponding periods in 2003. Under certain contracts, revenue is derived from both the SWU and uranium components of LEU. The volume of uranium sold increased 20% in the three months but declined 2% in the six months, and the average uranium price billed to customers increased 30% in the three and 28% in the six months ended June 30, 2004. The long-term market price for uranium hexafluoride, as published by TradeTech, was $56.09 per kilogram on June 30, 2004, compared with $46.50 on December 31, 2003, and $35.90 on June 30, 2003. Most of USECs uranium inventory has been committed under long-term sales contracts with utility customers, and the positive impact of the higher market prices is limited to sales under new contracts and to sales under contracts with prices based on market prices at the time of delivery.
USEC expects about one half of the SWU and uranium revenue for 2004 will be earned in the fourth quarter of 2004. Sales volumes and average price levels may be affected by a number of factors, including success in achieving sales targets and realization of average prices and estimates of inflation in contract price provisions. Shortfalls in volume or price could adversely affect revenue and results of operations.
Revenue from U.S. Government contracts increased $1.2 million (or 3%) in the three months but declined $1.1 million (or 1%) in the six months ended June 30, 2004, compared with the corresponding periods in 2003. The changes reflect changes in contract work performed. Revenue from U.S. Government contracts is based on allowable costs that are subject to audit by the Defense Contract Audit Agency. Allowable costs are based on cost accounting standards and include direct costs as well as allocations of indirect plant and corporate overhead costs. Audit adjustments could result in reductions in allowable costs that would adversely affect revenue and results of operations.
Government Investigation of Imports from France, Germany, the Netherlands and the United Kingdom
USEC believes its European competitors have curtailed unfair trading practices since the U.S. government began its investigation in 2000. This investigation led to the imposition of countervailing duty (anti-subsidy) orders on imports of LEU produced in France by Eurodif, S.A., and in Germany, the Netherlands and the United Kingdom by Urenco, Ltd. and an antidumping order on imports of LEU produced in France by Eurodif. The governments action has helped to restore stability to the enrichment market and ensure a long-term supply of competitive and reliable fuel.
16
The DOC recently conducted administrative reviews of its 2002 orders in order to establish the definitive countervailing and antidumping duties for imports of LEU in 2001 and 2002 and the deposit rates for future imports. The reviews resulted in margins of duty that were substantially lower than the margins estimated in the 2002 orders, indicating that Eurodif reduced its level of dumping and Eurodif and Urenco obtained fewer benefits from subsidization following the granting of trade relief in the DOCs original investigations. Based on the results of these reviews, the DOC calculated new estimated antidumping and countervailing duty rates of 5.43% and .71%, for a combined rate of 6.14%, that will apply to imports of LEU produced by Eurodif in lieu of the combined 32.1% rate that has applied since February 2002. Further, based on its conclusion that the subsidies conferred on Urenco ended in 2002, the DOC determined that no estimated rate will apply to imports of LEU produced by Urenco (the previous estimated rate was 2.23%). However, the existing countervailing duty order on imports of LEU from Urenco remains in force and Urenco could again face duties if found to have received subsidies in the future.
Cost of Sales
Cost of sales for SWU and uranium is based on the amount of SWU and uranium sold during the period and is determined by a combination of inventory levels and costs, production costs, and SWU purchase costs under the Russian Contract. Under the monthly moving average inventory cost method coupled with USECs inventory position, an increase or decrease in production or purchase costs will have an effect on inventory costs and cost of sales over future periods.
Cost of sales for SWU and uranium declined $55.8 million (or 20%) in the three months and $180.1 million (or 34%) in the six months ended June 30, 2004, compared with the corresponding periods in 2003. The reductions primarily resulted from the declines in the volume of SWU sold. Cost of sales per SWU improved 3% in the six-month period primarily as a result of the effect on inventory costs of purchases of SWU under the Russian Contract based on market-based pricing terms beginning in 2003.
Cost of sales for U.S. Government contracts declined $2.0 million (or 5%) in the three months and $5.3 million (or 7%) in the six months ended June 30, 2004, compared with the corresponding periods in 2003. The reductions reflect changes in the contract work performed.
The labor contract with the Paper, Allied-Industrial, Chemical and Energy Workers International Union (PACE) Local 5-689 covers 568 employees at the Portsmouth plant performing work under contracts with DOE and DOE contractors. In March 2004, USEC ratified a six-year labor contract with PACE at the Portsmouth plant.
(a) Purchase Costs under Russian Contract
Purchases of the SWU component of LEU under the Russian Contract declined $44.4 million (or 26 %) in the three months and $.9 million in the six months ended June 30, 2004, compared with the corresponding periods in 2003. The reduction in the three-month period reflects the timing of purchases. Purchase costs per SWU increased 3% in the six-month period. In June 2002, the U.S. and Russian governments approved implementation of new, market-based pricing terms for the remaining term of the Russian Contract through 2013. Beginning in 2003, prices are determined using a discount from an index of international and U.S. price points, including both long-term and spot prices. A multi-year retrospective of this index is used to minimize the disruptive effect of any
17
short-term market price swings. The amendment also provides that, after the end of 2007, USEC and the Russian Executive Agent may agree on appropriate adjustments, if necessary, to ensure that the Russian Executive Agent receives at least $7,565 million for the SWU component over the 20-year term of the Russian Contract through 2013. From inception of the Russian Contract in 1994 through June 30, 2004, USEC has purchased the SWU component of LEU at an aggregate cost of $3,420 million.
Under the amended contract, USEC agreed to purchase 5.5 million SWU each calendar year for the remaining term of the Russian Contract through 2013. Over the life of the 20-year Russian Contract, USEC expects to purchase 92 million SWU contained in LEU derived from 500 metric tons of highly enriched uranium. A significant delay in deliveries of LEU from Russia would have an adverse effect on USECs results of operations.
(b) Production Costs
Production costs consist principally of electric power, labor and benefits, depleted uranium disposition costs, materials, depreciation and amortization, and maintenance and repairs. Production levels and production costs at the Paducah plant were lower but unit production costs increased 3% in the six months ended June 30, 2004, compared with the corresponding period of 2003. Costs for electric power were lower reflecting the lower production but labor and employee benefit costs were higher, compared with the corresponding periods in 2003 when labor costs were reduced during a strike by PACE union employees at the Paducah plant. Power costs represented 59% of production costs in the six month period, compared with 61% in the corresponding period of 2003.
(c) Replacing Out-of-Specification Natural Uranium Inventory
Reference is made to information regarding out-of-specification uranium inventories transferred to USEC by DOE prior to privatization in 1998 and in the process of being remediated, reported in note 4 to the consolidated condensed financial statements.
(d) Environmental Matters
Reference is made to information regarding environmental matters involving Starmet CMI, the U.S. Environmental Protection Agency, the South Carolina Department of Health and Environmental Control, agencies of the U.S. Government, USEC and others, reported in note 10 to the consolidated condensed financial statements.
Gross Profit
Gross margin increased to 17.4% from 11.5% in the three months and to 14.2% from 11.1% in the six months ended June 30, 2004, compared with the corresponding periods in 2003 reflecting higher prices and margins on uranium. Gross profit for SWU and uranium increased $10.6 million (or 26%) in the three months but declined $9.9 million (or 13%) in the six-months ended June 30, 2004, compared with the corresponding periods in 2003. In the three-month period, the average uranium price billed to customers improved 30%, and the improvement was partly offset by lower SWU volume. The decline in gross profit in the six-month period resulted from the reductions in the volume and average price for SWU; the reductions were partly offset by the higher uranium prices.
18
Gross profit for U.S. Government contracts increased $3.2 million in the three months and $4.2 million in the six months ended June 30, 2004, compared with the corresponding periods in 2003. USEC began earning a fee on cold standby contract work in September 2003, and margins before selling, general and administrative expense improved as a result of DOEs approval of revised provisional billing rates.
Centrifuge Demonstration Costs
Demonstration costs for the American Centrifuge technology declined $.4 million (or 4%) in the three months and $.6 million (or 3%) in the six months ended June 30, 2004, compared with the corresponding periods in 2003. Engineering, assembling and testing of major components continues at centrifuge test facilities in Oak Ridge, Tennessee, and the first five project milestones under the DOE-USEC Agreement have been achieved on or ahead of schedule. USEC has entered into an agreement with DOE to temporarily lease portions of the Gas Centrifuge Enrichment Plant (GCEP) buildings in Piketon, Ohio and, under a contract with DOE, USEC is refurbishing a portion of the process buildings that will be used in the demonstration of the American Centrifuge technology. In February 2004, the NRC issued a license that authorizes USEC to construct and operate a lead cascade of centrifuge machines at the American Centrifuge Demonstration Facility. The demonstration facility is expected to begin operation in 2005 and will yield cost, schedule and performance data before USEC begins construction of the American Centrifuge Plant in 2007.
In June 2004, USEC selected Fluor Enterprises, Inc., a subsidiary of Fluor Corp., to provide engineering, procurement and construction management services for the American Centrifuge Plant in Piketon, Ohio. Fluors responsibilities over the next two years include design and detailed engineering. In 2006, USEC expects to agree on terms for a fixed-price contract with Fluor covering all major aspects of plant construction, apart from centrifuge machines. In August 2004, USEC plans to apply to the NRC for an operating license for the American Centrifuge Plant. NRC review is expected to take about two years.
The successful construction and operation of the American Centrifuge Plant is dependent upon a number of factors including, but not limited to, satisfactory performance of the American Centrifuge technology at various stages of demonstration, NRC licensing, financing of capital costs, and installation and operation of centrifuge machines and equipment. In addition, certain actions by DOE are required including USEC and DOE entering into a long-term agreement for the GCEP buildings and clean up of the buildings by DOE. In the event DOE fails to take appropriate and timely action, it could delay or disrupt USECs ability to meet the milestones scheduled in the DOE-USEC Agreement.
Selling, General and Administrative
Selling, general, and administrative expenses increased $1.1 million (or 7%) in the three months and $2.7 million (or 9%) in the six months ended June 30, 2004, compared with the corresponding periods in 2003. Compensation and employee benefit costs increased $1.1 million, legal and consulting fees increased $1.0 million, and insurance expense increased $.7 million in the six months ended June 30, 2004. Compensation costs increased as a result of higher salaries. Legal and consulting expenses reflect an increased level of effort relating to USECs strategic initiatives. The increase in insurance reflects higher premiums for directors and officers liability insurance.
19
USEC is taking steps in 2004 to reduce expenses below the 2003 level. As a percentage of revenue, expenses were 6.4% in the six months ended June 30, 2004, compared with 4.2% in the corresponding period of 2003; the increase reflects the lower revenue in the six months ended June 30, 2004. USEC expects the expenses will be 4.4% of revenue in 2004, compared with 4.8% in 2003.
Operating Income
Operating income increased $13.1 million (or 83%) in the three months but declined $7.8 million (or 29%) in the six months ended June 30, 2004, compared with the corresponding periods of 2003. The increase in the three-month period reflects higher margins on uranium, and the reduction in the six-month period reflects the decline in SWU revenue.
Provision for Income Taxes
The provision for income taxes reflects an effective income tax rate of 38% in the six months ended June 30, 2004, compared with 42% in the corresponding period of 2003. The tax rate in 2004 reflects higher export tax incentives.
Net Income
Net income increased $7.4 million ($.09 per share) in the three months but declined $5.9 million ($.07 per share) in the six months ended June 30, 2004, compared with the corresponding periods of 2003. The increase in the three-month period reflects higher margins on uranium, and the reduction in the six-month period reflects the decline in SWU revenue.
2004 Outlook
USEC expects net income for 2004 in a range of $14 to $16 million (or $.17 to $.19 per share) based on higher volume and prices for natural uranium and improved SWU pricing. A small loss is anticipated in the third quarter of 2004.
USEC projects revenue for 2004 will be almost $1.4 billion with approximately half of the revenue in the fourth quarter of 2004 due to the timing of the customer orders. Total revenue is basically unchanged from earlier guidance, but revenue from sales of uranium is expected to be $40 million higher at $210 million due to higher volume and prices. The additional uranium available for sale is the result of underfeeding operations at the Paducah plant. Revenue from sales of SWU is expected to decline on lower volume due to the movement of customer orders but will benefit from modestly higher average prices billed to customers that are higher than originally projected and about the same as in 2003. SWU volume in 2004 is negatively affected by the postponed refuelings due to the shutdown of a Japanese customers reactors for special inspections and by lower contractual commitments from customers. Higher uranium sales are expected to improve gross margin to 13% in 2004, compared with 11% in 2003.
USEC expects to spend approximately $70 million on demonstration and deployment of the American Centrifuge technology in 2004. Of this amount, approximately $50 million relates to demonstration activities and is being charged to expense which has the effect of reducing net income by about $30 million. Costs of approximately $20 million related to the American Centrifuge Plant are being capitalized in 2004.
20
USEC expects that cash flow from operating activities will be in a range of negative $95 to $105 million in 2004 and that capital expenditures will approximate $35 million, including expenditures related to the American Centrifuge Plant. USEC anticipates ending 2004 with a cash balance in a range of $55 to $70 million.
Liquidity and Capital Resources
Liquidity and Cash Flows
Net cash outflow from operating activities amounted to $190.6 million in the six months ended June 30, 2004, compared with net cash inflow of $23.1 million in the corresponding period of 2003. Cash outflow in the six months ended June 30, 2004, reflects a net inventory increase or temporary build up of $194.9 million, the payment of a previously accrued obligation of $33.2 million resulting from the settlement of termination obligations under the OVEC power purchase agreement, and income tax payments of $8.1 million, partly offset by a decline of $51.5 million in accounts receivable.
Net cash flow from operating activities amounted to $23.1 million in the six months ended June 30, 2003. Cash flow was reduced by deliveries against advances from customers that result in non-cash revenue, the timing of purchases under the Russian Contract, and the timing of collections of trade receivables.
Capital expenditures amounted to $11.2 million in the six months ended June 30, 2004, compared with $14.9 million in the corresponding period of 2003. Capital expenditures in the 2004 period include $4.5 million for capitalized centrifuge costs associated with the American Centrifuge Plant.
The issuance of common stock, primarily from the exercise of stock options, added $8.1 million to cash flow from financing activities in the six months ended June 30, 2004. There were 84.3 million shares of common stock outstanding at June 30, 2004, compared with 82.6 million at December 31, 2003.
Dividends paid to stockholders amounted to $23.0 million (or a quarterly rate of $.1375 per share) in the six months ended June 30, 2004, about the same as in the corresponding period of 2003. Beginning in December 2002, cash dividends are charged against excess of capital over par value in the stockholders equity section.
Working Capital
A summary of working capital is as follows (in millions):
June 30, | December 31, | |||||||
2004 | 2003 | |||||||
Cash and cash equivalents |
$ | 32.4 | $ | 249.1 | ||||
Accounts receivable |
203.0 | 254.5 | ||||||
Inventories, net |
1,071.1 | 838.2 | ||||||
Accounts payable and other assets, net |
(267.9 | ) | (326.7 | ) | ||||
Working capital |
$ | 1,038.6 | $ | 1,015.1 | ||||
21
Cash and cash equivalents amounted to $32.4 million at June 30, 2004, compared with $249.1 million at December 31, 2003. The reduction of $216.7 million reflects the net cash outflow from operating activities, principally inventories. Inventories included in current assets, net of uranium owed to customers and suppliers, increased $232.9 million (or 28%) reflecting the temporary build-up of SWU inventories in anticipation of planned low production levels in the summer months when power costs are very high and the high levels of customer orders for deliveries scheduled in the fourth quarter of 2004. USEC expects about one half of the SWU and uranium revenue for 2004 will be earned in the fourth quarter of 2004.
There were no short-term borrowings at June 30, 2004 or December 31, 2003. USEC expects to temporarily borrow under the credit agreement later in 2004 and expects to repay such borrowings by the end of 2004.
In February 2004, USEC paid a previously accrued obligation of $33.2 million resulting from the settlement of termination obligations under the OVEC power purchase agreement.
Long-term Liabilities
The long-term liability for the disposition of depleted uranium declined $24.6 million (or 46%) and the long-term asset for the prepayment and deposit for depleted uranium declined $23.6 million (or 50%) at June 30, 2004, compared with December 31, 2003. The reductions reflect the transfer of depleted uranium to DOE under the terms of a 1998 Memorandum of Agreement.
Capital Structure and Financial Resources
In January 1999, USEC issued $350.0 million of 6.625% senior notes due January 2006 and $150.0 million of 6.750% senior notes due January 2009. The senior notes are unsecured obligations and rank on a parity with all other unsecured and unsubordinated indebtedness of USEC Inc.
In September 2002, United States Enrichment Corporation, a wholly owned subsidiary of USEC, entered into a three-year syndicated revolving credit facility. The facility provides up to $150 million in revolving credit commitments (including up to $50 million in letters of credit) until September 2005 and is secured by certain assets of the subsidiary and, subject to certain conditions, certain assets of USEC. Borrowings under the new facility are subject to limitations based on percentages of eligible accounts receivable and inventory. Obligations under the facility are fully and unconditionally guaranteed by USEC.
Outstanding borrowings under the facility bear interest at a variable rate equal to, based on the borrowers election, either (i) the sum of (x) the greater of the JPMorgan Chase Bank prime rate or the federal funds rate plus 1/2 of 1% plus (y) a margin ranging from .75% to 1.25% based upon collateral availability or (ii) the sum of LIBOR plus a margin ranging from 2.5% to 3% based on collateral availability. The revolving credit facility includes various operating and financial covenants that are customary for transactions of this type, including, without limitation, restrictions on the incurrence and prepayment of other indebtedness, granting of liens, sales of assets, making of investments, maintenance of a minimum amount of inventory, and payment of dividends or other distributions. The new facility does not restrict USECs payment of common stock dividends at the current level, subject to the maintenance of a specified minimum level of collateral. Failure to satisfy the covenants would constitute an event of default. At June 30, 2004, USEC was in compliance with covenants under the revolving credit facility.
22
The total debt-to-capitalization ratio was 36% at June 30, 2004, and December 31, 2003. In July 2004, Moodys affirmed its negative outlook on USEC, lowered the rating on USECs senior notes ($500 million) to Ba3 from Ba2, lowered the senior implied rating to Ba2 from Ba1, and placed the ratings under review for possible further downgrade. In October 2003, Standard & Poors affirmed the outlook on USEC as stable and affirmed the BB- rating of the senior notes, the BB corporate credit rating, and the BBB- rating for the revolving credit facility.
USEC expects that its cash, internally generated funds from operations, and available financing under the revolving credit facility will be sufficient over the next twelve months to meet its obligations as they become due and to fund operating requirements and capital expenditures, purchases of SWU under the Russian Contract, interest expense, American Centrifuge demonstration costs, and quarterly dividends. USEC expects to renegotiate the revolving credit facility that provides $150 million in revolving credit commitments prior to expiration of the facility in September 2005, and to identify alternatives to retire or refinance the first installment of senior notes amounting to $350 million that is scheduled to mature in January 2006.
Quantitative and Qualitative Disclosures about Market Risk
At June 30, 2004, the balance sheet carrying amounts for cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, and payables under the Russian Contract approximate fair value because of the short-term nature of the instruments.
USEC does not enter into financial instruments for trading purposes. The fair value of long-term debt is calculated based on a credit-adjusted spread over U.S. Treasury securities with similar maturities. The scheduled maturity dates of long-term debt, the balance sheet carrying amounts and related fair values at June 30, 2004, are as follows (in millions):
Maturity Dates | June 30, 2004 | |||||||||||||||
January | January | Balance Sheet | Fair | |||||||||||||
2006 | 2009 | Carrying Amount | Value | |||||||||||||
Long-term debt: |
||||||||||||||||
6.625% senior notes |
$ | 350.0 | $ | 350.0 | $ | 350.0 | ||||||||||
6.750% senior notes |
$ | 150.0 | 150.0 | 145.5 | ||||||||||||
$ | 500.0 | $ | 495.5 | |||||||||||||
23
Controls and Procedures
Disclosure Controls and Procedures
Management, with the participation of the President and Chief Executive Officer and the Senior Vice President and Chief Financial Officer, has evaluated the effectiveness of the disclosure controls and procedures as of June 30, 2004. Based on such evaluation, management, including the President and Chief Executive Officer and the Senior Vice President and Chief Financial Officer, concluded that the disclosure controls and procedures are effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by USEC in the reports that it files or submits under the Securities Exchange Act of 1934.
Internal Control over Financial Reporting
There have not been any changes in USECs internal control over financial reporting during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, USECs internal control over financial reporting.
24
USEC Inc.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
Environmental Matters
In 1998, USEC contracted with Starmet CMI (Starmet) to convert a small portion of USECs depleted uranium into a form that could be used in certain beneficial applications or disposed of at existing commercial disposal facilities. In 2002, Starmet ceased operations at its Barnwell, South Carolina facility.
In November 2002, USEC received notice from the U.S. Environmental Protection Agency (EPA) that EPA was undertaking removal action under the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA), as amended (commonly known as Superfund), to clean up two evaporation ponds and remove and dispose of certain drums and other material located at Starmets Barnwell site containing uranium and other byproducts of Starmets activities at the site. The notice also stated that EPA believed USEC as well as other parties, including agencies of the U.S. Government, are potentially responsible parties (PRPs) under CERCLA. In February 2004, USEC and certain federal agencies who have been identified as PRPs under CERCLA entered into an agreement with EPA, under which USEC is responsible for removing certain material from the site that is attributable to quantities of depleted uranium USEC had sent to the site. USEC has engaged contractors to remove and dispose of such material.
At June 30, 2004, USEC has an accrued liability of $8.1 million representing its current estimate of its share of costs to comply with the EPA settlement agreement and other costs associated with the Starmet facility. Additional costs could be incurred due to a number of factors including, but not limited to, increases in costs associated with the removal and disposal of material from the Starmet site, increases in costs associated with remediation of the evaporation ponds, or a decision by EPA or the South Carolina Department of Health and Environmental Control to perform additional remediation at the site after completion of the removal and disposal activities. An allocation of costs to USEC in excess of the amounts that USEC has accrued at June 30, 2004, could have an adverse effect on USECs results of operations.
Other
USEC is subject to various other legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business. While the outcome of these claims cannot be predicted with certainty, USEC does not believe that the outcome of any of these legal matters will have a material adverse effect on its results of operations or financial condition.
25
Item 4. Submission of Matters to a Vote of Security Holders
USEC held its annual meeting of shareholders on April 29, 2004. As of the record date, March 5, 2004, there were 83.5 million shares of common stock outstanding and entitled to vote. 95% of those shares were represented at the annual meeting.
A board of eight directors (listed below) was elected at the annual meeting. Each director holds office until the next annual meeting of shareholders and until his or her successor is elected and has qualified. There were no abstentions or broker non-votes. The number of votes cast for and withheld follows (in millions):
For | Withheld | |||||||
James R. Mellor, Chairman |
70.0 | 8.9 | ||||||
Michael H. Armacost |
70.1 | 8.9 | ||||||
Joyce F. Brown |
70.2 | 8.7 | ||||||
John R. Hall |
70.1 | 8.9 | ||||||
W. Henson Moore |
70.3 | 8.6 | ||||||
Joseph F. Paquette, Jr. |
70.3 | 8.7 | ||||||
William H. Timbers |
70.0 | 8.9 | ||||||
James D. Woods |
70.0 | 8.9 |
The following items were also voted on at the annual meeting (in millions):
Broker | ||||||||||||||||
For | Against | Non-votes | Abstain | |||||||||||||
First amendment to and the
performance goals under the
USEC Inc. 1999 Equity
Incentive Plan |
31.8 | 21.2 | 25.7 | .2 | ||||||||||||
Appointment of
PricewaterhouseCoopers LLP
as independent auditors for
2004 |
76.3 | 2.5 | | .1 | ||||||||||||
Shareholder Proposal No.1
relating to top executive
compensation |
6.2 | 46.6 | 25.7 | .5 | ||||||||||||
Shareholder Proposal No.2
relating to a proxy
advisor |
4.2 | 48.5 | 25.7 | .6 |
26
Item 6. Exhibits and Reports on Form 8-K
(a) Exhibits.
10.67 |
Stock Purchase Agreement, dated July 29, 2004, by and among Pinnacle | |
West Capital Corporation, El Dorado Investment Company and USEC Inc. | ||
31.1 |
Certification of the Chief Executive Officer pursuant to | |
Rule 13a-14(a)/15d-14(a). | ||
31.2 |
Certification of the Chief Financial Officer pursuant to | |
Rule 13a-14(a)/15d-14(a). | ||
32 |
Certification of CEO and CFO pursuant to 18 U.S.C. Section 1350, as | |
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
(b) Reports on Form 8-K.
On April 22, 2004, USEC filed a current report on Form 8-K to furnish its press release, dated April 21, 2004, announcing financial results for the three months ended March 31, 2004.
On June 4, 2004, USEC filed a current report on Form 8-K announcing that the USEC Benefits Administration Committee engaged Grant Thornton LLP as the independent registered public accounting firm for the USEC Savings Plan, dismissing PricewaterhouseCoopers LLP.
On July 14, 2004, USEC filed a current report on Form 8-K to furnish its press release, dated July 13, 2004, updating earnings guidance for 2004.
On July 30, 2004, USEC filed a current report on Form 8-K to furnish its press release, dated July 29, 2004, announcing that it had entered into a definitive agreement to acquire NAC International.
27
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
USEC Inc. | ||||
August 6, 2004
|
By | /s/ Ellen C. Wolf | ||
Ellen C. Wolf Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) |
28
EXHIBIT INDEX
Exhibit | ||
Number | Description | |
10.67 |
Stock Purchase Agreement, dated July 29, 2004, by and among Pinnacle West | |
Capital Corporation, El Dorado Investment Company and USEC Inc. | ||
31.1 |
Certification of the Chief Executive Officer pursuant to | |
Rule 13a-14(a)/15d-14(a). | ||
31.2 |
Certification of the Chief Financial Officer pursuant to | |
Rule 13a-14(a)/15d-14(a). | ||
32 |
Certification of CEO and CFO pursuant to 18 U.S.C. Section 1350, as adopted | |
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
29